Literature DB >> 26763099

Acute-phase glycoprotein N-glycome of ovarian cancer patients analyzed by CE-LIF.

Stefan Weiz1,2, Marta Wieczorek1, Christian Schwedler1,2, Matthias Kaup1, Elena Iona Braicu3, Jalid Sehouli3, Rudolf Tauber1, Véronique Blanchard1.   

Abstract

Epithelial ovarian cancer (EOC) is the most frequent cause of death from all gynecological malignancies because of its late diagnosis. As N-glycosylation is modified in the course of ovarian cancer, it is a promising source of tumor biomarkers. In this work, serum glycoproteins, depleted from albumin and IgG, were separated by 2DE. Protein spots of acute-phase proteins were identified by peptide mapping and their corresponding glycan moieties were released enzymatically, fluorescently labeled and analyzed by CE-LIF. In the positive acute-phase proteins, haptoglobin, α1-antitrypsin, and α1-antichymotrypsin, an increase of antennarity and Lewis(X) motif could be measured in EOC patients on tri- and/or tetraantennary N-glycans. Tetraantennary N-glycans containing three Lewis(X) epitopes and triantennary N-glycans containing a β(1-6) branch and a Lewis(X) epitope were only present in EOC patients. We also showed for the first time that the core-fucosylated biantennary digalactosylated N-glycan of α1-acid glycoprotein is a potential biomarker for EOC. To conclude, core-fucosylated biantennary N-glycans on α1-acid glycoprotein as well as higher antennarity and increased amounts of Lewis(X) motif on haptoglobin, α1-antitrypsin, and α1-antichymotrypsin are promising biomarkers for EOC. Nevertheless, their specificity and selectivity for the early detection of EOC should be evaluated in a larger study.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Acute-phase protein; CE-LIF; N-glycan; Ovarian cancer

Mesh:

Substances:

Year:  2016        PMID: 26763099     DOI: 10.1002/elps.201500518

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  14 in total

Review 1.  Recent Advances in the Analysis of Complex Glycoproteins.

Authors:  Stefan Gaunitz; Gabe Nagy; Nicola L B Pohl; Milos V Novotny
Journal:  Anal Chem       Date:  2016-11-23       Impact factor: 6.986

2.  State-of-the-Art Glycomics Technologies in Glycobiotechnology.

Authors:  Alexander Pralow; Samanta Cajic; Kathirvel Alagesan; Daniel Kolarich; Erdmann Rapp
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Capillary (Gel) Electrophoresis-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

Authors:  Samanta Cajic; René Hennig; Robert Burock; Erdmann Rapp
Journal:  Exp Suppl       Date:  2021

4.  Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.

Authors:  Yiqing Pan; Lei Zhang; Rongrong Zhang; Jing Han; Wenjun Qin; Yong Gu; Jichen Sha; Xiaoyan Xu; Yi Feng; Zhipeng Ren; Jiawen Dai; Ben Huang; Shifang Ren; Jianxin Gu
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

5.  Sample Preparation Scale-Up for Deep N-glycomic Analysis of Human Serum by Capillary Electrophoresis and CE-ESI-MS.

Authors:  Marton Szigeti; Andras Guttman
Journal:  Mol Cell Proteomics       Date:  2019-10-18       Impact factor: 5.911

Review 6.  Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.

Authors:  Mengmeng Wang; Jianhui Zhu; David M Lubman; Chunfang Gao
Journal:  Clin Chem Lab Med       Date:  2019-03-26       Impact factor: 8.490

Review 7.  Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases.

Authors:  Yanxia Jin; Weidong Wang; Qiyun Wang; Yueyang Zhang; Kashif Rafiq Zahid; Umar Raza; Yongsheng Gong
Journal:  Cancer Cell Int       Date:  2022-04-19       Impact factor: 6.429

8.  iTRAQ-Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha-1-Antitrypsin as Potential Biomarkers.

Authors:  Yu Yang; Junmeng Wei; Xuekuan Huang; Mingjun Wu; Zhenbing Lv; Pan Tong; Rui Chang
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-27       Impact factor: 2.629

Review 9.  Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.

Authors:  Athanasios Blanas; Neha M Sahasrabudhe; Ernesto Rodríguez; Yvette van Kooyk; Sandra J van Vliet
Journal:  Front Oncol       Date:  2018-02-23       Impact factor: 6.244

10.  Serum N-glycome alterations in colorectal cancer associate with survival.

Authors:  Stefan W de Vroome; Stephanie Holst; Mar Rodriguez Girondo; Yuri E M van der Burgt; Wilma E Mesker; Rob A E M Tollenaar; Manfred Wuhrer
Journal:  Oncotarget       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.